Prolonged effect of liposomes encapsulating pilocarpine HCl in normal and glaucomatous rabbits

International Journal of Pharmaceutics

Volumn 198, Issue 1, 2000, Pages 29-38

  Monem, A Soltan ^a   Ali, Fadel M ^a   Ismail, Medhat W ^b  

^a CAIRO UNIVERSITY   (Egypt)

^b RESEARCH INSTITUTE OF OPHTHALMOLOGY   (Egypt)

Author keywords

Glaucomatous pigmented rabbits; Intraocular pressure (IOP); Light scattering; Liposome characterization; Pilocarpine hydrochloride

Indexed keywords

PILOCARPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG BIOAVAILABILITY; FEMALE; GLAUCOMA; INTRAOCULAR PRESSURE; LIGHT SCATTERING; MICROENCAPSULATION; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RABBIT;

1,2-DIPALMITOYLPHOSPHATIDYLCHOLINE; ALGORITHMS; ANIMALS; BIOLOGICAL AVAILABILITY; CAPSULES; DRUG COMPOUNDING; FEMALE; GLAUCOMA; INTRAOCULAR PRESSURE; LIGHT; LIPOSOMES; MUSCARINIC AGONISTS; PARTICLE SIZE; PILOCARPINE; RABBITS; SCATTERING, RADIATION;

EID: 0034732054     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(99)00348-8     Document Type: Article

References (26)

1. Bangham A.D., Hill M.W., Miller N.G.A. Preparation and use of liposomes as models of biological membranes. Karn E.D. Methods in Membrane Biology. 1:1974;1-68 Plenum, New York.
2. Bayvel L.P., Jones A.R. Electromagnetic Scattering and Its Applications. 1981;Applied Science, London.
3. Benita S., Plenecassagne J.D., Caves G., Drouin D., Le Hao Dong P., Sincholle D. Pilocarpine hydrochloride liposomes: characterization in vitro and preliminary evaluation in vivo in rabbit eye. J. Microencapsulation. 1:1984;203-211.
4. Benson H. Permeability of the cornea to topically applied drugs. Arch. Ophthalmol. 91:1974;313-327.
5. Bloomfield S.E., Miyata T., Dunn M.W., Buseser N., Stenzel K.H., Rubin A.L. Soluble gentamicin ophthalmic inserts as a drug delivery system. Arch. Ophthalmol. 96:1978;885-887.
6. Chen S., Strurtevant J.M., Gaffney B.H. Scanning calorimetric evidence for a third phase transition in phosphatidylcholine bilayer. Proc. Natl. Acad. Sci. USA. 77(9):1980;5060-5068.
7. Fitzgerald P., Hadgraft J., Kreuter J., Wilson C.G. A γ-scintigraphic evaluation of microparticulate ophthalmic delivery systems: liposomes and nanoparticles. Int. J. Pharm. 40:1987;81.
8. Gregoriadis G., Florence A.T. Liposomes in drug delivery clinical, diagnostic and ophthalmic potential. Drugs. 45(1):1993;15-28.
9. Hanna C. Delivery of antibiotics to the eye. Life Sci. 27:1980;2509-2512.
10. Hanna C., Massey J.Y., Hendrikson R.O., Williamson J., Jones E.M., Wilson P. Ocular penetration of topical chloramphenicol in humans. Arch. Ophthalmol. 96:1978;1258-1261.
11. Kompella U.B., Katragadda A.K., Aukunuru J.V., Betageri G.V. Effect of liposomal charge on stavudine transport across rabbit cornea and conjunctiva. Pharm. Pharmacol. Commun. 4:1998;339-343.
12. Ladbrooke B.D., Williams R.M., Chapman D. Biochem. Biophys. Acta. 150:1968;333-342.
13. Maurice H., Luntz F.R.C.S. Experimental glaucoma in the rabbit. Am. J. Ophthalmol. 61:1966;665-680.
14. Meisner D., Mezei M. Liposome ocular delivery systems. Adv. Drug Delivery Rev. 16:1995;75-93.
15. Meisner D., Pringle J., Mezei M. Liposomal ophthalmic drug delivery system III: pharmacodynamic and biodisposition studies of atropine. Int. J. Pharm. 55:1989;105.
16. Monem, A.S., 1986, Ph.D. Thesis, Southampton University, UK.
17. Niesman M.R. The use of liposomes as drug carriers in ophthalmology. Crit. Rev. Ther. Drug Carrier Syst. 9(1):1992;1-38.
18. El-Gazayerly O.N., Hikal A.H. preparation and evaluation of acetazolamide liposomes as an ocular delivery system. Int. J. Pharm. 158:1997;121-127.
19. Patton T.F., Francoeur M. Ocular bioavailability and systemic loss of topically applied ophthalmic drugs. Am. J. Ophthalmol. 5:1978;225-229.
20. Salminen L., Urtti A., Periviita L. Effects of ocular pigmentation on pilocarpine pharmacology in the rabbit eye. Drug distribution and metabolism. Int. J. Pharm. 18:1984;17-24.
21. Shaeffer H.E., Krohn D.L. Liposomes in topical drug delivery. Invest. Ophthalmol. Vis. Sci. 22:1982;220-227.
22. Shek P.N., Barber R.F. Liposomes are effective carriers for the ocular delivery of prophylactics. Biochem. Biophys. Acta. 902:1987;229-236.
23. Shields M.B. Textbook of Glaucoma. 2nd ed:1987;45-70 Wavery, USA. Ch. 3.
24. Singh K., Mezei M. Liposomal ophthalmic drug delivery system I: triamcinolone acetonide. Int. J. Pharm. 16:1983;339-344.
25. Singh K., Mezei M. Liposomal ophthalmic drug delivery system II: dihydrostreptomycin sulphate. Int. J. Pharm. 19:1984;263-269.
26. Taniguchi K., Yamamoto Y., Itakura K., Miichi H., Hayashi S. Assessment of ocular irritability of liposome preparations. J. Pharmacobiol. Dyn. 11:1988;607-615.